Latest Period
Q2 2026
Security Snapshot
Cardiol Therapeutics Inc. - Class A Common Shares (CRDL) Institutional Ownership
CUSIP: 14161Y200
13F Institutional Holders and Ownership History from Q4 2019 to Q2 2026
Institutions Reporting
52
Shares (Excl. Options)
29,482,969
Price
$1.06
Save this security page for your next review
Keep this CUSIP in your watchlists so you can revisit quarter changes from one place. If you create an account from here, we will bring you back after verification.
- Security type / class
- Equity / Class A Common Shares
- Symbol
- CRDL on Nasdaq
- All holders as of 30 Jun 2026
- Q2 2026
- Total 13F shares
- 29,482,969
- Total 13F value
- $31,250,347
- Portfolio coverage rank
- 0%
- Share change
- +1,666,185
- Value change
- +$1,703,350
- Number of holders
- 52
- Shares outstanding
- 121,080,108
- SEC-reported price per share
- $1.21
Latest holder snapshot
5 signals
Issuer context
Names, identifiers, and filing context for this profile.
2 identity fields
13F Shares, Excluding Options vs Price
13F Value, Excluding Options
Total Investors
Key facts
- CRDL - Cardiol Therapeutics Inc. - Class A Common Shares is tracked under CUSIP 14161Y200.
- 52 institutions reported positions in Q2 2026.
- 2 significant owners is listed from Schedule 13D/13G reporting.
Change
- Holder count moved from 46 to 52 between Q1 2026 and Q2 2026.
- SEC-reported value moved from $37,577,318 to $31,250,347.
Research use
- You can quickly see who holds this security, then open quarter and manager detail pages for full evidence.
- 13F and Schedule 13D/13G sections are kept together so you can cross-check institutional and beneficial ownership context.
Evidence
Source: SEC Form 13F
Open SEC evidence
Latest holder context comes from 52 institutions filings for Q2 2026.
Security key
14161Y200
Latest holder period
Q2 2026
13F holders
52
13D/G owners
2
CIK / CUSIP context first
Open Q2 2026 holders
CRDL full holder history
Cardiol Therapeutics Inc. SEC filings
Cardiol Therapeutics Inc. company facts
Broader feeds
Recent Quarterly Holder Reports
Open recent reporting periods for CUSIP 14161Y200:
13D/G owners
Significant owners
Large-stake holder rows connected to Schedule 13D/G evidence.
Rows
2
Security
CRDL
| Filer | Ownership | Change % | Holdings Value | Net Change | Nb Shares | Change % | Reporting Name | Report Period |
|---|---|---|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 18% | -1.7% | $21,523,200 | +$248,705 | 21,310,099 | +1.2% | MMCAP International Inc. SPC | 30 Jun 2026 |
| Tejara Capital Ltd | 5.2% | $5,323,528 | 5,130,122 | Tejara Capital Ltd | 17 Oct 2025 |
As of 30 Jun 2026, 52 institutional investors reported holding 29,482,969 shares of Cardiol Therapeutics Inc. - Class A Common Shares (CRDL). This represents 24% of the company’s total 121,080,108 outstanding shares.
13F concentration
Top 25 institutional shareholders
Largest 13F positions for this security by reported shares and value.
Top holder share
24%
| Institution | Ownership % | Shares Held | Share Change % | Portfolio % | Holdings Value |
|---|---|---|---|---|---|
| MMCAP International Inc. SPC | 13% | 15,598,560 | +1.6% | 1.4% | $16,534,474 |
| Tejara Capital Ltd | 4.2% | 5,113,822 | -0.32% | 2.2% | $5,420,651 |
| Ikarian Capital, LLC | 2.7% | 3,325,000 | +22% | 0.58% | $3,524,500 |
| BOOTHBAY FUND MANAGEMENT, LLC | 0.81% | 975,721 | +23% | 0.02% | $1,034,264 |
| CITADEL ADVISORS LLC | 0.66% | 796,529 | -2.9% | 0% | $844,320 |
| RENAISSANCE TECHNOLOGIES LLC | 0.64% | 772,837 | +236% | 0% | $819,207 |
| TWO SIGMA INVESTMENTS, LP | 0.62% | 746,937 | +40% | 0% | $791,753 |
| INTEGRITY ALLIANCE, LLC. | 0.32% | 388,492 | -16% | 0.01% | $411,802 |
| MORGAN STANLEY | 0.29% | 355,030 | +42% | 0% | $376,332 |
| GOLDMAN SACHS GROUP INC | 0.28% | 333,900 | +0.45% | 0% | $353,934 |
| PVG ASSET MANAGEMENT CORP | 0.09% | 107,165 | 0% | 0.07% | $113,595 |
| 1832 Asset Management L.P. | 0.08% | 100,000 | 0% | 0% | $106,000 |
| MGO ONE SEVEN LLC | 0.08% | 100,000 | 0% | 0% | $106,000 |
| Summit Financial, LLC | 0.08% | 99,109 | -4.8% | 0% | $105,056 |
| JANE STREET GROUP, LLC | 0.04% | 53,416 | -58% | 0% | $56,065 |
| JPMORGAN CHASE & CO | 0.04% | 48,077 | 0% | 0% | $49,519 |
| HRT FINANCIAL LP | 0.04% | 47,179 | 0% | $50,000 | |
| ACADIAN ASSET MANAGEMENT LLC | 0.04% | 44,255 | 0% | $45,000 | |
| GEODE CAPITAL MANAGEMENT, LLC | 0.03% | 42,196 | -20% | 0% | $44,727 |
| Marble Harbor Investment Counsel, LLC | 0.03% | 39,900 | 0% | 0% | $42,294 |
| Boyer Financial Services, Inc. | 0.03% | 34,100 | +48% | 0.03% | $35,805 |
| Quadrature Capital Ltd | 0.03% | 30,566 | -36% | 0% | $32,400 |
| Kovack Advisors, Inc. | 0.02% | 30,000 | 0% | 0% | $31,500 |
| Concurrent Investment Advisors, LLC | 0.02% | 25,387 | 0% | $26,910 | |
| MERCER GLOBAL ADVISORS INC /ADV | 0.02% | 22,600 | 0% | 0% | $23,956 |
Quarter history
Institutional holders across reporting periods
Holder count, reported shares/value, and median price by quarter.
Periods
26
Latest
Q2 2026
Rows shown
1-25 of 26
| Period | 13F Shares, Excl. Options | Value, Excl. Options | Value Change | Price (Median) | Investors |
|---|---|---|---|---|---|
| 2026 Q2 | 29,482,969 | $31,250,347 | +$1,703,350 | $1.06 | 52 |
| 2026 Q1 | 27,859,784 | $37,577,318 | +$25,774,247 | $1.35 | 46 |
| 2025 Q4 | 9,101,664 | $8,688,287 | +$1,769,497 | $0.95 | 41 |
| 2025 Q3 | 7,282,619 | $7,797,682 | +$687,878 | $1.07 | 47 |
| 2025 Q2 | 6,465,422 | $8,796,830 | -$1,669,184 | $1.36 | 38 |
| 2025 Q1 | 7,719,601 | $7,435,013 | +$182,305 | $0.97 | 38 |
| 2024 Q4 | 7,493,301 | $9,599,808 | +$3,011,551 | $1.28 | 43 |
| 2024 Q3 | 4,972,709 | $9,852,940 | -$780,395 | $1.98 | 41 |
| 2024 Q2 | 5,391,195 | $10,832,854 | -$2,207,214 | $2.02 | 41 |
| 2024 Q1 | 6,466,600 | $11,532,275 | +$17,221 | $1.81 | 32 |
| 2023 Q4 | 6,828,316 | $5,921,144 | +$428,207 | $0.84 | 29 |
| 2023 Q3 | 6,315,038 | $5,705,102 | -$336,357 | $0.90 | 31 |
| 2023 Q2 | 6,680,430 | $5,957,333 | -$451,394 | $0.89 | 30 |
| 2023 Q1 | 7,243,437 | $3,537,761 | +$172,240 | $0.49 | 31 |
| 2022 Q4 | 5,656,495 | $2,897,996 | +$187,861 | $0.51 | 28 |
| 2022 Q3 | 4,751,290 | $4,889,869 | -$537,769 | $1.03 | 22 |
| 2022 Q2 | 5,288,416 | $6,964,240 | -$155,145 | $1.32 | 24 |
| 2022 Q1 | 5,387,006 | $8,272,481 | -$917,566 | $1.54 | 26 |
| 2021 Q4 | 5,796,080 | $10,710,997 | +$7,739,960 | $1.85 | 27 |
| 2021 Q3 | 1,605,991 | $6,624,465 | +$6,624,465 | $4.13 | 19 |
| 2021 Q1 | 0 | $0 | -$970,000 | $1.21 | 0 |
| 2020 Q4 | 348,769 | $970,000 | +$171,498 | $2.78 | 1 |
| 2020 Q3 | 287,106 | $876,000 | +$133,036 | $3.05 | 1 |
| 2020 Q2 | 243,504 | $577,000 | +$78,276 | $2.37 | 1 |
| 2020 Q1 | 210,470 | $600,000 | +$50,715 | $2.85 | 1 |